Articles tagged "Risk factors"

2019 American Transplant Congress
Quantifying Differential Infection Risks in HLA- and/or ABO- Incompatible Kidney Transplant Recipients
R. Avery¹, R. Montgomery², J. Motter¹, A. Massie¹, E. Kraus¹, K. Marr¹, B. Lonze², N. Alachkar¹, K. Jackson¹, M. Holechek¹, D. Ostrander¹, N. Desai¹, M. Waldram¹, S. Shoham¹, S. Mehta¹, J. Hiller¹, J. Langlee¹, S. Young¹, D. Segev¹, J. Garonzik Wang¹
¹Johns Hopkins, Baltimore, MD, ²New York University, New York, NY
*Purpose: Desensitization has enabled kidney transplantation across HLA-and/or ABO barriers and has conferred survival benefit to patients who lack compatible living donors (CLDKT). However, due…
2019 American Transplant Congress
Trimming the Fat?: Optimizing Utilization of Liver Allografts with Macrosteatosis >30% in Recipients with MELD Scores <35
J. A. Steggerda¹, M. B. Bloom¹, T. Todo², T. V. Brennan², N. N. Nissen², A. S. Klein², I. K. Kim²
¹Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ²Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA
*Purpose: Macrosteatosis (MaS) >30% in liver allografts has been associated with increased risk of primary non-function and poor graft survival. This study assesses the influence…
2019 American Transplant Congress
Risk Factors for Recurrent Urinary Tract Infections and Antimicrobial Resistant Organisms in Kidney Transplant Recipients
S. Greissman¹, A. Mattiazzi², J. Quinonez¹, M. Grady¹, R. Zukerman¹, A. Wawrzyniak³, M. Morris⁴, S. Anjan⁴, J. Simkins⁴, J. Camargo⁴, L. Abbo⁵
¹University of Miami Miller School of Medicine, Miami, FL, ²Department of Transplant Nephrology, University of Miami Miller School of Medicine, Miami, FL, ³Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, ⁴Department of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, ⁵Department of Infection Control and Prevention and Antimicrobial Stewardship, University of Miami Miller School of Medicine, Miami, FL
*Purpose: Up to 20% of urinary tract infections (UTIs) in kidney transplant (KT) recipients are caused by multidrug-resistant organisms (MDROs). The risk factors for developing…
2019 American Transplant Congress
Predictive Factors for BKV Nephropathy in Renal Transplant Recipients with BK Viruria
I. Alshaer, M. Bottomley, S. Mehta, J. Galante, I. Roberts, E. Sharples
Renal, Oxford University Hospitals, Oxford, United Kingdom
*Purpose: Polyoma infection due to BK virus remains an important cause of allograft failure following renal transplantation.Intensive monitoring of urine and serum for BK virus…
2019 American Transplant Congress
Determining the Role of Insurance Coverage at the Time of Renal Transplantation as a Predictor of Medication Misadventure
D. Wilkerson, P. Klem
Pharmacy, University of Colorado Skaggs School of Pharmacy, Aurora, CO
*Purpose: To determine if patients who receive financial assistance through the American Kidney Fund (AKF) for health care premiums at the time of transplant are…
2019 American Transplant Congress
Factors Related to International Travel for Transplantation among US-Listed Kidney Transplant Candidates
B. Koons¹, M. L. Henderson², A. G. Thomas³, T. Kear⁴, H. Moriarty⁴
¹School of Nursing, University of Pennsylvania, Philadelphia, PA, ²Department of Surgery in the Division of Transplantation, Johns Hopkins University, Baltimore, MD, ³Department of Epidemiology, University of North Carolina, Chapel Hill, NC, ⁴M. Louise Fitzpatrick College of Nursing, Villanova University, Villanova, PA
*Purpose: The aim of this study was to identify factors associated with international travel for transplantation among US-listed kidney transplant (KT) candidates.*Methods: Using 2010-2016 data…
2019 American Transplant Congress
Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study
V. Dharnidharka¹, D. Axelrod², Z. Zhang³, M. Schnitzler³, K. Lentine³, B. Kasiske⁴
¹Washington Univ, St. Louis, MO, ²Univ of Iowa, Iowa City, IA, ³Saint Louis Univ, St. Louis, MO, ⁴SRTR, Minneapolis, MN
*Purpose: From our CISTEM study of linked national registries, we reported that older recipient age, female sex, diabetic kidney failure, non-standard-criteria organs, and mTORi-based IS…
2019 American Transplant Congress
The Risks Are Not Always The Same; Peak Timing Of Risk In Liver Transplantation
K. Sasaki, J. McVey, D. Firl, K. Okubo, M. Fujiki, T. Diago Uso, D. Kwon, B. Eghtesad, C. Quintini, C. Miller, F. Aucejo, K. Hasimoto
Cleveland Clinic, Cleveland, OH
*Purpose: Numerous risk factors are known to affect liver transplantation (LT). Previous studies suggest that a combination of favorable and unfavorable factors is essential in…
2019 American Transplant Congress
Pneumocystis jirovecii Pneumonia among Kidney Transplant Recipients: The Forgotten Infection
L. Bowman¹, R. Baliga², K. Zeitler¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: In the era of prophylaxis, pneumocystis jirovecii pneumonia (PJP) is a rare post-transplant complication, particularly among kidney transplant recipients (KTR). Cases of PJP in…
2019 American Transplant Congress
Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index
M. Gupta¹, M. Barry², M. Levine³, K. Olthoff³, A. Shaked³, P. Abt³
¹University of Kentucky, Lexington, KY, ²University of California, San Francisco, San Francisco, CA, ³University of Pennsylvania, Philadelphia, PA
*Purpose: Most morbidity and mortality after pediatric liver retransplantation (LRTx) occurs in the first 100 days. We studied factors associated with mortality and graft failure…